The Effect of Alternative Prosthetic Alignments on Sit-to-Stand Proficiency in Transtibial Amputees

NCT ID: NCT04657614

Last Updated: 2021-07-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

7 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-17

Study Completion Date

2021-07-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this graduate student research study is to determine the effect of various linear and angular prosthetic alignments on K1-K3 unilateral or bilateral TT amputees, as well as test for proficiency, comfort, balance, heart rate and fit during sit to stands.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Initial Visit:

1. Informed consent
2. HIPAA
3. Foot Inspection
4. Review expectations
5. Take measurements
6. Casting

Second Visit: Fitting and adjusting accordingly.

* One person will conduct all the measurements, casting, check sockets, etc. to evade inconsistencies in data collection.
* Begin conducting practice runs on Balance Master at LLU-East Campus.

Third, Fourth and Fifth Visit: Testing (5-10-minute rest period in between each test) \*Testing will be video recorded for re-assessment of subjects\*

1. Five times sit-to-stand test (5XSTS).
2. Activities-Specific Balance Confidence (ABC-16) scale
3. Balance Master:

Weight Bearing Squat (WBS) Unilateral Stance (US) Sensory Organization Test (SOT) modified Clinical Test of Sensory Interaction on Balance (mCTSIB) Limits of Stability (LOS)
4. A Polar H10 heart rate monitor will be worn while subjects perform each of the various tests.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amputation Balance Prosthesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants
A sock will be placed over the prosthesis in order for the participant to not know which alignment is used.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Neutral Alignment Group

A straight pylon with the ankle at neutral.

Group Type EXPERIMENTAL

Neutral Alignment

Intervention Type OTHER

Alignment that is a neutral replicate of the participants prescribed prosthesis.

Anterior Alignment Group

An anteriorly displaced pylon with ankle dorsiflexion at 5 degrees.

Group Type EXPERIMENTAL

Anterior Alignment

Intervention Type OTHER

Alignment that is anterior displaced pylon.

Posterior Alignment Group

A posteriorly displaced pylon with 5 degrees of plantarflexion at the ankle.

Group Type EXPERIMENTAL

Posterior Alignment

Intervention Type OTHER

Alignment that is posteriorly displaced pylon.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neutral Alignment

Alignment that is a neutral replicate of the participants prescribed prosthesis.

Intervention Type OTHER

Anterior Alignment

Alignment that is anterior displaced pylon.

Intervention Type OTHER

Posterior Alignment

Alignment that is posteriorly displaced pylon.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Male and Female below knee amputees (bi-lateral or unilateral)

* 18-70 years of age
* K1-K3 (K-levels/activity levels)

* K1=patient has the ability or potential to use a prosthesis for transfers or walking on level surfaces at a fixed speed (typical limited or unlimited household ambulator).
* K2=patient has the ability or potential for walking with the ability to traverse most low-level environmental barriers such as curbs, stairs, or uneven surfaces (typical community ambulator).
* K3=patient has the ability or potential for walking with variable speed. Has the ability to traverse most environmental barriers and may have vocational, exercise, or recreational activities that demand prosthetic use beyond simple locomotion.
* Those who wear a prosthesis daily for the purpose of walking
* Able to get in and out of a chair
* Prosthetic foot that has the same functional components as the subject's current one

Exclusion Criteria

Amputation at birth

* Foot amputation at ankle
* Uncontrolled edema in leg compartments
* Compromised skin of the residual limb
* Patients that are 3 months or less post-amputation
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Loma Linda University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michael Davidson

Assistant Professor Orthotics and Prosthetics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Davidson, MSE MPH

Role: PRINCIPAL_INVESTIGATOR

Loma Linda University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Loma Linda University

Loma Linda, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5200455

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.